Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · IEX Real-Time Price · USD

2.140

+0.050 (2.39%)

At close: Apr 25, 2024, 4:00 PM

2.150

+0.010 (0.47%)

After-hours: Apr 25, 2024, 7:30 PM EDT

Revelation Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Selling, General & Admin	4.51	5.49	5.04	0.15
Research & Development	4.15	5.38	6.91	0
Operating Expenses	8.66	10.86	11.95	0.15
Operating Income	-8.66	-10.86	-11.95	-0.15
Other Expense / Income	-8.54	-0.03	0.04	1.49
Pretax Income	-0.12	-10.83	-11.99	-1.63
Net Income	-0.12	-10.83	-11.99	-1.63
Shares Outstanding (Basic)	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0
Shares Change	215.00%	672.10%	309.63%	-
EPS (Basic)	-0.53	-149.20	-1275.00	-714.00
EPS (Diluted)	-0.53	-149.20	-1275.00	-714.00
Free Cash Flow	-7.29	-11.22	-11.22	-1.42
Free Cash Flow Per Share	-31.87	-154.57	-1193.74	-618.88
EBITDA	-0.1	-10.79	-11.92	-1.63
Depreciation & Amortization	0.03	0.04	0.07	0
EBIT	-0.12	-10.83	-11.99	-1.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).